Evercore ISI raised the firm’s price target on Henry Schein (HSIC) to $90 from $83 and keeps an Outperform rating on the shares. The dental market is stabilizing and operational improvements are underway, while the anticipation of a new CEO announcement in Q4 adds to the momentum, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC: